Exelixis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,147

Employees1,147

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,147

Employees1,147

EXEL Key Statistics

Market cap

10.54B

Market cap10.54B

Price-Earnings ratio

18.78

Price-Earnings ratio18.78

Dividend yield

—

Dividend yield—

Average volume

2.56M

Average volume2.56M

High today

$39.30

High today$39.30

Low today

$38.50

Low today$38.50

Open price

$38.72

Open price$38.72

Volume

2.48M

Volume2.48M

52 Week high

$49.62

52 Week high$49.62

52 Week low

$25.17

52 Week low$25.17

EXEL News

Simply Wall St 5d

Exelixis: Evaluating Valuation After Phase 3 Study Halt, Revenue Miss, and Legal Investigation News

If you’re holding or eyeing shares of Exelixis (EXEL), you’re probably watching the recent news very closely. The company just revealed it will not move forward...

TipRanks 6d

Exelixis Advances Phase 1 Study of XL309 for Advanced Solid Tumors

Exelixis ((EXEL)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

Analyst ratings

55%

of 20 ratings

Buy

55%

Hold

45%

Sell

People also own

Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.

Sprouts Farmers Market